Shield Therapeutics plc (STX.L)

GBp 2.75

(0.0%)

Operating Income Summary of Shield Therapeutics plc

Shield Therapeutics plc's latest annual operating income in 2023 was -31.33 Million GBP , down -11.86% from previous year.
Shield Therapeutics plc's latest quarterly operating income in 2024 Q2 was -11.15 Million GBP , down 0.0% from previous quarter.
Shield Therapeutics plc reported an annual operating income of -25.7 Million GBP in 2022, down -28.84% from previous year.
Shield Therapeutics plc reported an annual operating income of -19.95 Million GBP in 2021, down -957.9% from previous year.
Shield Therapeutics plc reported a quarterly operating income of -15.86 Million GBP for 2023 Q4, down 0.0% from previous quarter.
Shield Therapeutics plc reported a quarterly operating income of -12.84 Million GBP for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Income Chart of Shield Therapeutics plc (2023 - 2014)

Historical Annual Operating Income of Shield Therapeutics plc (2023 - 2014)

Year	Operating Income	Operating Income Growth
2023	-31.33 Million GBP	-11.86%
2022	-25.7 Million GBP	-28.84%
2021	-19.95 Million GBP	-957.9%
2020	-1.88 Million GBP	79.13%
2019	-9.03 Million GBP	-74.83%
2018	-5.16 Million GBP	75.33%
2017	-20.95 Million GBP	-68.15%
2016	-12.46 Million GBP	-93.66%
2015	-6.43 Million GBP	-89.74%
2014	-3.39 Million GBP	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	-11.15 Million GBP	0.0%
2023 Q4	-15.86 Million GBP	0.0%
2023 Q2	-12.84 Million GBP	0.0%
2023 FY	-28.75 Million GBP	-11.86%
2022 Q2	-11.72 Million GBP	0.0%
2022 FY	-25.7 Million GBP	-28.84%
2022 Q4	-14.68 Million GBP	0.0%
2021 Q2	-7.64 Million GBP	0.0%
2021 Q4	-13.43 Million GBP	0.0%
2021 FY	-19.95 Million GBP	-957.9%
2020 Q4	-4.54 Million GBP	0.0%
2020 Q2	2.39 Million GBP	0.0%
2020 FY	-1.88 Million GBP	79.13%
2019 FY	-9.03 Million GBP	-74.83%
2019 Q2	-2.54 Million GBP	0.0%
2018 Q4	2.91 Million GBP	0.0%
2018 FY	-5.16 Million GBP	75.33%
2018 Q2	- GBP	0.0%
2017 FY	-20.95 Million GBP	-68.15%
2017 Q2	- GBP	0.0%
2017 Q4	- GBP	0.0%
2016 Q4	- GBP	0.0%
2016 FY	-12.46 Million GBP	-93.66%
2016 Q2	- GBP	0.0%
2015 FY	-6.43 Million GBP	-89.74%
2014 FY	-3.39 Million GBP	0.0%

Peer Operating Income Comparison of Shield Therapeutics plc

Name	Operating Income	Operating Income Difference